Allarity Therapeutics Files 2025 Proxy Statement
Ticker: ALLR · Form: DEF 14A · Filed: Apr 30, 2025 · CIK: 1860657
Sentiment: neutral
Topics: proxy-statement, annual-meeting, governance
TL;DR
Allarity's 2025 proxy statement is out, shareholders vote June 13th.
AI Summary
Allarity Therapeutics, Inc. filed its definitive proxy statement on April 30, 2025, for its annual meeting of stockholders on June 13, 2025. The filing covers the fiscal year ending December 31, 2024. The company is incorporated in Delaware and its principal executive offices are located at 24 School St., 2nd Floor, Boston, MA.
Why It Matters
This filing provides shareholders with essential information regarding the upcoming annual meeting, including voting matters and company performance, enabling informed participation in corporate governance.
Risk Assessment
Risk Level: low — This is a routine regulatory filing (DEF 14A) that provides information to shareholders and does not inherently introduce new financial risks.
Key Numbers
- 2024-12-31 — Fiscal Year End (Reporting period for financial information)
Key Players & Entities
- Allarity Therapeutics, Inc. (company) — Registrant
- 0001860657 (company) — Central Index Key
- 20250430 (date) — Filing Date
- 20250613 (date) — Meeting Date
- 24 School St., 2nd Floor, Boston, MA 02108 (address) — Business Address
FAQ
What is the purpose of a DEF 14A filing?
A DEF 14A filing, or definitive proxy statement, is used by companies to solicit proxies from shareholders for an upcoming meeting, providing detailed information about the matters to be voted upon.
When is the annual meeting of Allarity Therapeutics, Inc. shareholders scheduled?
The annual meeting of Allarity Therapeutics, Inc. shareholders is scheduled for June 13, 2025.
What is the Central Index Key (CIK) for Allarity Therapeutics, Inc.?
The Central Index Key (CIK) for Allarity Therapeutics, Inc. is 0001860657.
Where are Allarity Therapeutics, Inc.'s principal executive offices located?
Allarity Therapeutics, Inc.'s principal executive offices are located at 24 School St., 2nd Floor, Boston, MA 02108.
What is the filing date of this definitive proxy statement?
This definitive proxy statement was filed on April 30, 2025.
Filing Details
This Form DEF 14A (Form DEF 14A) was filed with the SEC on April 30, 2025 regarding Allarity Therapeutics, Inc. (ALLR).